Centaur Labs Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Centaur Labs Inc. - overview
Established
2017
Location
Boston, MA, US
Primary Industry
Healthcare IT
About
Founded in 2017 and based in Massachusetts, US, Centaur Labs Inc. operates a medical AI-based to labeling medical images at scale. The company was co-founded by Erik Duhaime, Tom Gellatly, and Zach Rausnitz, and as of September 2021, Centaur Labs Inc. Centaur has cultivated a network of 10,000 medical students and professionals from over 140 countries.
In October 2024, Centaur Labs Inc. raised USD 16 million in series B funding led by new investor SignalFire, with participation from returning investors Omega Venture Partners, Y Combinator, Accel, Matrix Partners, and Susa Ventures. Other new investors Samsung NEXT Ventures and Alumni Ventures Group also participated in the round. The company developed an application called DiagnosUs designed to gather labelers and will reward with cash based on their performance enabling patients and healthcare companies to reduce costs and improve healthcare outcomes.
The company will use the funding to scale operations and accelerate product development for providing high-quality, efficient medical data annotation to healthcare and AI companies.
Current Investors
Accel, Global Founders Capital, Hack VC
Primary Industry
Healthcare IT
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Healthcare IT
Website
www.centaurlabs.com
Verticals
Artificial Intelligence, HealthTech, Mobile Apps
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.